ESMO Young Oncologist Journal Club

The ESMO Young Oncologists Committee is proud to host the Young Oncologist Journal Club. On a regular basis (1-3 times a month), a committee member – or a specially invited young oncologists – provides you with an appraisal of an important clinical and/or translational article published in a major journal. The appraisers add their comments analysing the clinical relevance of the article and possible considerations.

Filter

Topic Title Author
Gastrointestinal cancers BILCAP trial: is capecitabine the winner in the adjuvant therapy of biliary tract cancer? Valeria Merz
Gastrointestinal cancers "Is It a Kind Of MAGIC?" Shah Zeb Khan
Central nervous system malignancies Improving Overall survival with adjuvant Lomustine-temozolomide in patients with newly diagnosed glioblastoma with methylated MGMT promoter Mohamed Alorabi
Genitourinary cancers CARMENA trial: Should cytoreductive nephrectomy be dismissed in the treatment of metastatic Renal Cell Carcinoma in the era of targeted therapy? Pier Vitale Nuzzo
Gynaecologic malignancies PORTEC-3: Do we need a deeper insight into the appropriateness of chemoradiotherapy? Anindya Mukherjee
Melanoma and other skin tumours Adjuvant Dabrafenin plus Trametinib in BRAF mutant Stage III Melanoma Pasquale Vitale
Central nervous system malignancies Is there a role for adjuvant chemotherapy in anaplastic gliomas? The CATNON TRIAL Leonor Pinto
Genitourinary cancers Immune-checkpoint Inhibition on the Rise - Rapidly Shifting Paradigms in the Treatment of Urothelial Carcinoma Christoph Oing
Genitourinary cancers Abiraterone in castrate-sensitive prostate cancer Manuel Maia, Sumanta Pal
Lung and other thoracic tumours How To Overcome EGFR Mutation Resistance In Lung Cancer Mohamed Emam Salah
Breast cancer A decade after completion of the HERA trial: where are we in the adjuvant treatment of patients with HER2-positive early breast cancer? Arlindo R. Ferreira, Matteo Lambertini
Lung and other thoracic tumours Necitumumab plus Paclitaxel-Carboplatin in first line treatment of patients with stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) Ioannis Litos, Eleni Sogka
Gynaecologic malignancies Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer Christoph Oing
Lung and other thoracic tumours Pembrolizumab Versus Chemotherapy for PD-L1 Positive Non-Small-Cell Lung Cancer (NSCLC) Julia Martinez Perez
Palliative and supportive care Measuring the Benefit of Palliative Care for Effective Integration into Standard Cancer Care Rita Canário